Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-24-000126
Filing Date
2024-05-09
Accepted
2024-05-09 14:53:43
Documents
30
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl0506form10q.htm   iXBRL 10-Q 213318
2 EXHIBIT 31.1 cncl0506form10qexh31_1.htm EX-31.1 8071
3 EXHIBIT 31.2 cncl0506form10qexh31_2.htm EX-31.2 8085
4 EXHIBIT 32.1 cncl0506form10qexh32_1.htm EX-32.1 3752
  Complete submission text file 0001554795-24-000126.txt   1097414

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cncl-20240331.xsd EX-101.SCH 10011
6 XBRL CALCULATION FILE cncl-20240331_cal.xml EX-101.CAL 20035
7 XBRL DEFINITION FILE cncl-20240331_def.xml EX-101.DEF 10311
8 XBRL LABEL FILE cncl-20240331_lab.xml EX-101.LAB 95295
9 XBRL PRESENTATION FILE cncl-20240331_pre.xml EX-101.PRE 68070
34 EXTRACTED XBRL INSTANCE DOCUMENT cncl0506form10q_htm.xml XML 47380
Mailing Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111
Business Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

EIN.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 24929997
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)